首页> 美国政府科技报告 >Clinical Evaluation of Xylazine for Chemical Restraint of Captive Arctic Wolves ('Canis lupus').
【24h】

Clinical Evaluation of Xylazine for Chemical Restraint of Captive Arctic Wolves ('Canis lupus').

机译:甲苯噻嗪对圈养北极狼('犬狼疮')化学抑制的临床评价。

获取原文

摘要

Xylazine at doses of 2.7 to 3.9 mg/kg was administered to 23 captive arctic wolves over a period of 2 1/2 years. Optimum dose was higher for excited and socialized adults and lower for juveniles that for unexcited unsocialized adults. Time to initial effect averaged 2.5 minutes, and sternal recumbency occurred at 3.7 minutes. Maximal effect was achieved by 15 minutes with adequate sedation lasting 30 to 60 minutes. Mean recovery time was longer for older adults than for younger ones (2.4 vs 1.7 hours). Induction of and recovery from intravenous barbiturate general anesthesia was smooth and quiet in xylazine-premedicated animals. Although a few adverse reactions were found, the use of xylazine with physical restraint was an excellent combination for many clinical procedures. (Author)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号